01 1Natco Pharma
01 1IMATINIB MESYLATE (ALPHA 2-FORM)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-28
Pay. Date : 2013-09-19
DMF Number : 20410
Submission : 2007-04-05
Status : Active
Type : II
20
Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IMATINIB MESYLATE (ALPHA 2-FORM), with a corresponding US DMF Number 20410.
Remarkably, this DMF maintains an Active status since its submission on April 05, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 28, 2013, and payment made on September 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
